PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 26 filers reported holding PROQR THRAPEUTICS N V in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $224,000 | -5.1% | 72,796 | -0.4% | 0.00% | – |
| Q4 2017 | $236,000 | -40.3% | 73,096 | -10.3% | 0.00% | – |
| Q3 2017 | $395,000 | -0.8% | 81,494 | +6.5% | 0.00% | – |
| Q2 2017 | $398,000 | +4.2% | 76,494 | 0.0% | 0.00% | – |
| Q1 2017 | $382,000 | +1.9% | 76,494 | 0.0% | 0.00% | – |
| Q4 2016 | $375,000 | -26.5% | 76,494 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $510,000 | +37.8% | 76,494 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $370,000 | -3.1% | 76,494 | -2.3% | 0.00% | 0.0% |
| Q1 2016 | $382,000 | -43.8% | 78,294 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $680,000 | -43.9% | 78,294 | -6.0% | 0.00% | -50.0% |
| Q3 2015 | $1,213,000 | -10.9% | 83,250 | +2.0% | 0.00% | 0.0% |
| Q2 2015 | $1,361,000 | -18.0% | 81,640 | +7.7% | 0.00% | 0.0% |
| Q1 2015 | $1,659,000 | +1.5% | 75,800 | +0.5% | 0.00% | -33.3% |
| Q4 2014 | $1,634,000 | – | 75,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |